Scientists at Gladstone Institutes discover blood protein fibrin initiates toxic inflammation and neuron loss after major head injury, potentially informing treatments for traumatic brain injury.
Scientists at Gladstone Institutes have discovered a blood coagulation protein that initiates toxic inflammation and neuron loss after a major head injury. This new therapeutic target could inform the development of treatments for traumatic brain injury, which affects around 1.5 million Americans each year and often presents long-term health challenges. The study, led by Jae Kyu Ryu, found that the blood protein fibrin plays a causative role in brain damage, suggesting potential avenues for targeted interventions to prevent long-term harm.
April 19, 2024
9 Articles